首页 | 本学科首页   官方微博 | 高级检索  
     

3种头孢菌素类抗生素治疗下呼吸道感染的成本-效果分析
引用本文:符红波,周勇,郑奕辉. 3种头孢菌素类抗生素治疗下呼吸道感染的成本-效果分析[J]. 中南药学, 2004, 2(3): 175-176
作者姓名:符红波  周勇  郑奕辉
作者单位:汕头大学医学院第二附属医院,汕头,515041
摘    要:
目的评价3种头孢菌素类抗生素治疗下呼吸道感染的成本-效果.方法运用药物经济学成本-效果分析法对头孢哌酮钠-舒巴坦钠组(A组)、头孢唑肟钠组(B组)、拉氧头孢钠组(C组)3种治疗方案进行回顾性分析评价.结果3种治疗方案中,头孢哌酮钠-舒巴坦钠组成本最低.结论3种头孢菌素类抗生素中,头孢哌酮钠-舒巴坦钠是治疗下呼吸道感染的最佳药物.

关 键 词:成本-效果分析  下呼吸道感染  药物经济学  头孢菌素类
文章编号:1672-2981(2004)03-0175-02

Cost-effectiveness analysis of 3 cephalosporins in lower respiratory tract infections
Fu Hong-bo,Zhou Yong,Zheng Yi-hui. Cost-effectiveness analysis of 3 cephalosporins in lower respiratory tract infections[J]. Central South Pharmacy, 2004, 2(3): 175-176
Authors:Fu Hong-bo  Zhou Yong  Zheng Yi-hui
Abstract:
OBJECTIVE To evaluate the cost-effectiveness of 3 of cephalosporins in treating lower respiratory tract infections. METHODS We evaluated the 3 treating projects in retrospect by cost-effectiveness analysis, including cefoperazone-sulbactam sodium (Group A), ceftizoxime sodium (Group B), and latamoxef sodium (Group C).RESULTS Among the 3 treatment protocols, the cost of cefoperazone-sulbactam sodium was the lowest. CONCLUSIONS Cefoperazone-sulbactam sodium is the best one among the 3 antibiotics of cephalosporins in treating the lower respiratory tract infections.
Keywords:cost-effective ness analysis  lower respiratory tract infection  pharmacoeconomics  cephalosporins
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号